Please provide your email address to receive an email when new articles are posted on . Tapinarof cream 1% showed low discontinuation rates. The cream has no restriction of use. Tapinarof patients ...
- VTAMA® (tapinarof) cream, 1% demonstrated early, significant, and meaningful achievement of both no-to-minimal itch (mean weekly PP-NRS≤1) and sleep improvement in ADORING 1 and ADORING 2. - 31.4% ...
I struggle with getting good sleep. What can I do about it? Try heating up your feet at night with one of these methods: Warming the extremities before bed has been shown to help people fall asleep ...
Post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs, published in the Journal of the European Academy of Dermatology and Venereology, highlight nemolizumab’s fast onset of ...
MONDAY, Dec. 22, 2025 (HealthDay News) -- Nemolizumab rapidly relieves itch and sleep disturbance among patients with moderate-to-severe atopic dermatitis (AD) and prurigo nodularis (PN), according to ...
Nowadays, people adopt various methods to get a peaceful sleep, but due to the hectic life and work pressure, people complain of insomnia, due to which they are unable to sleep the whole night, and ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results